Abstract
Circulating fetal cell-free DNA (cffDNA) is emerging as the most reliable known target for prenatal molecular diagnostics. Different points of view are expressed in literature regarding the safe use of cffDNA for all types of molecular tests, above all those used to detect maternal DNA rather than fetal mutation. The aim of the present study was therefore to achieve consensus on guidelines conducive to standardizing current procedures, which differ between laboratories, and to design stringent technical protocols for the analysis of cffDNA.
References
1. Rava RP, Srinivasan A, Sehnert AJ, Bianchi DW. Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X. Clin Chem 2014;60:243–50.10.1373/clinchem.2013.207951Search in Google Scholar
2. Lo YM. Non-invasive prenatal testing using massively parallel sequencing of maternal plasma DNA: from molecular karyotyping to fetal whole-genome sequencing. Reprod Biomed Online 2013;27:593–8.10.1016/j.rbmo.2013.08.008Search in Google Scholar
3. Lim JH, Lee DE, Kim KS, Kim HJ, Lee BY, Park SY, et al. Non-invasive detection of fetal trisomy 21 using fetal epigenetic biomarkers with a high CpG density. Clin Chem Lab Med 2013;18:1–7.Search in Google Scholar
4. Wu H, Huang G, Romay-Penabad Z, Pierangeli S, Dong J. Do we need to worry about contamination by circulating fetal DNA? Clin Chem Lab Med 2014;52:e75–7.10.1515/cclm-2013-0726Search in Google Scholar
5. Krafft AE, Lichy JH. Time-motion analysis of 6 cystic fibrosis mutation detection systems. Clin Chem 2005;51:1116–22.10.1373/clinchem.2004.047423Search in Google Scholar
6. Minucci A, Canu G, Concolino P, Guarino D, Boccia S, Ficarra S, et al. DNA from buccal swab is suitable for rapid genotyping of angiotensin-converting enzyme insertion/deletion (I/D) polymorphism. Clin Chim Acta 2014;431:125–3010.1016/j.cca.2013.12.041Search in Google Scholar
7. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, Chan KC, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br Med J 2011;342:c7401.10.1136/bmj.c7401Search in Google Scholar
8. Wong D, Moturi S, Angkachatchai V, Mueller R, De Santis G, van den Boom D, et al. Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing. Clin Biochem 2013;46:1099–104.10.1016/j.clinbiochem.2013.04.023Search in Google Scholar
9. Rosner M, Hengstschläger M. Amniotic fluid stem cells and fetal cell microchimerism. Trends Mol Med 2013;19:271–2.10.1016/j.molmed.2013.01.001Search in Google Scholar
10. Coata G, Picchiassi E, Centra M, Fanetti A, Maulà V, Benedetto C, et al. Persistence of male hematopoietic CD34+ cells in the circulation of women does not affect prenatal diagnostic techniques. Am J Obstet Gynecol 2009;200:528.e1–7.10.1016/j.ajog.2008.12.019Search in Google Scholar
11. Jensen TJ, Zwiefelhofer T, Tim RC, Džakula Ž, Kim SK, Mazloom AR, et al. High-throughput massively parallel sequencing for fetal aneuploidy detection from maternal plasma. PLoS One 2013;8:e57381.10.1371/journal.pone.0057381Search in Google Scholar
12. Deans Z, Hill M, Chitty LS, Lewis C. Non-invasive prenatal testing for single gene disorders: exploring the ethics. Eur J Hum Genet 2013;21:713–8.10.1038/ejhg.2012.250Search in Google Scholar
©2014 by Walter de Gruyter Berlin/Boston